These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39133666)

  • 1. Anti-Müllerian hormone and fertility in women after childhood cancer treatment: Association with current infertility risk classifications.
    Nyström A; Mörse H; Øra I; Henic E; Engellau J; Wieslander E; Tomaszewicz A; Elfving M
    PLoS One; 2024; 19(8):e0308827. PubMed ID: 39133666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
    Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
    Parissone F; Di Paola R; Balter R; Garzon S; Zaffagnini S; Neri M; Vitale V; Tridello G; Cesaro S
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):25-33. PubMed ID: 33068384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.
    van den Berg MH; Overbeek A; Lambalk CB; Kaspers GJL; Bresters D; van den Heuvel-Eibrink MM; Kremer LC; Loonen JJ; van der Pal HJ; Ronckers CM; Tissing WJE; Versluys AB; van der Heiden-van der Loo M; Heijboer AC; Hauptmann M; Twisk JWR; Laven JSE; Beerendonk CCM; van Leeuwen FE; van Dulmen-den Broeder E;
    Hum Reprod; 2018 Aug; 33(8):1474-1488. PubMed ID: 29982673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
    Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
    Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: a review.
    Drechsel KCE; Pilon MCF; Stoutjesdijk F; Meivis S; Schoonmade LJ; Wallace WHB; van Dulmen-den Broeder E; Beishuizen A; Kaspers GJL; Broer SL; Veening MA
    Hum Reprod Update; 2023 Jul; 29(4):486-517. PubMed ID: 36779325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility.
    Greenwood EA; Cedars MI; Santoro N; Eisenberg E; Kao CN; Haisenleder DJ; Diamond MP; Huddleston HG;
    Fertil Steril; 2017 Dec; 108(6):1070-1077. PubMed ID: 29202959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
    Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
    J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review.
    Anderson RA; Cameron D; Clatot F; Demeestere I; Lambertini M; Nelson SM; Peccatori F
    Hum Reprod Update; 2022 May; 28(3):417-434. PubMed ID: 35199161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 10-year follow up of reproductive function in women treated for childhood cancer.
    Nielsen SN; Andersen AN; Schmidt KT; Rechnitzer C; Schmiegelow K; Bentzen JG; Larsen EC
    Reprod Biomed Online; 2013 Aug; 27(2):192-200. PubMed ID: 23768622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
    Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
    Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years.
    Khan HL; Bhatti S; Suhail S; Gul R; Awais A; Hamayun H; Enver F; Abbas S; Hassan Z; Nisar R; Sardar S; Asif W
    Reprod Biol Endocrinol; 2019 Feb; 17(1):20. PubMed ID: 30744650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cigarette smoking on serum anti-Mullerian hormone and antral follicle count in women seeking fertility treatment: a prospective cross-sectional study.
    Bhide P; Timlick E; Kulkarni A; Gudi A; Shah A; Homburg R; Acharya G
    BMJ Open; 2022 Mar; 12(3):e049646. PubMed ID: 35361635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadal Function in Female Adolescent and Young Adult Survivors of Childhood Cancer.
    Jin HY; Lee JA; Park M; Park HJ
    Cancer Res Treat; 2023 Jul; 55(3):992-1000. PubMed ID: 36731461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility preservation in childhood and adolescent female tumor survivors.
    Filippi F; Meazza C; Somigliana E; Podda M; Dallagiovanna C; Massimino M; Raspagliesi F; Terenziani M
    Fertil Steril; 2021 Oct; 116(4):1087-1095. PubMed ID: 34238574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of ovarian reserve and quality of life in female survivors of pediatric cancer.
    Nilsson S; Jarfelt M; Järvholm S; Kluge L; Thurin-Kjellberg A
    Acta Obstet Gynecol Scand; 2022 Jan; 101(1):84-93. PubMed ID: 34783360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFE.
    van der Perk MEM; Broer L; Yasui Y; Laven JSE; Robison LL; Tissing WJE; Versluys B; Bresters D; Kaspers GJL; Lambalk CB; Overbeek A; Loonen JJ; Beerendonk CCM; Byrne J; Berger C; Clemens E; van Dulmen-den Broeder E; Dirksen U; van der Pal HJ; de Vries ACH; Winther JF; Ranft A; Fosså SD; Grabow D; Muraca M; Kaiser M; Kepák T; Kruseova J; Modan-Moses D; Spix C; Zolk O; Kaatsch P; Kremer LCM; Brooke RJ; Wang F; Baedke JL; Uitterlinden AG; Bos AME; van Leeuwen FE; Ness KK; Hudson MM; van der Kooi ALF; van den Heuvel-Eibrink MM;
    Fertil Steril; 2024 Sep; 122(3):514-524. PubMed ID: 38729340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.